In this video, Victor H. Gonzalez, MD, discusses “exciting” presentations at Clinical Trials at the Summit on wet age-related macular degeneration treatments, specifically those on tyrosine kinase ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Age-related macular degeneration (AMD) is the leading cause of visual impairment among elderly in the world. Early detection of AMD is of great importance, as the vision loss caused by this disease is ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Market is one of the leading causes of irreversible vision loss in individuals aged 50 and above. With the global aging population increasing rapidly, the burden of AMD is escalating, pushing the ...

Send comments and news tips to [email protected]. Cite this: Edited by Shrabasti Bhattacharya. Intensive Bevacizumab Boosts Vision in Macular Degeneration - Medscape - June 19, 2025.

Alternative Anti-VEGF Treatment Regimens in Exudative Age-related Macular Degeneration Robert B Bhisitkul; Jay M Stewart Disclosures Expert Rev Ophthalmol. 2010;5 (6):799-809. 0 ...

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Methods We reviewed baseline examinations of patients with neovascular age-related macular degeneration using multimodal imaging. We determined the type and distribution of MNV lesions in each cMNV3 ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.